Hong Kong · Delayed Price · Currency is HKD Essex Bio-Technology Statistics
Total Valuation
HKG:1061 has a market cap or net worth of HKD 1.28 billion. The enterprise value is 826.08 million.
| Market Cap | 1.28B |
| Enterprise Value | 826.08M |
Important Dates
The last earnings date was Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | Aug 18, 2026 |
Share Statistics
HKG:1061 has 566.00 million shares outstanding. The number of shares has decreased by -0.42% in one year.
| Current Share Class | 566.00M |
| Shares Outstanding | 566.00M |
| Shares Change (YoY) | -0.42% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 54.17% |
| Owned by Institutions (%) | 0.99% |
| Float | 259.37M |
Valuation Ratios
The trailing PE ratio is 4.85 and the forward PE ratio is 3.98.
| PE Ratio | 4.85 |
| Forward PE | 3.98 |
| PS Ratio | 0.75 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | 5.89 |
| P/OCF Ratio | 4.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.04, with an EV/FCF ratio of 3.78.
| EV / Earnings | 3.11 |
| EV / Sales | 0.48 |
| EV / EBITDA | 2.04 |
| EV / EBIT | 2.40 |
| EV / FCF | 3.78 |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.15 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.86 |
| Debt / FCF | 1.60 |
| Interest Coverage | 35.65 |
Financial Efficiency
Return on equity (ROE) is 11.01% and return on invested capital (ROIC) is 12.16%.
| Return on Equity (ROE) | 11.01% |
| Return on Assets (ROA) | 6.27% |
| Return on Invested Capital (ROIC) | 12.16% |
| Return on Capital Employed (ROCE) | 12.14% |
| Weighted Average Cost of Capital (WACC) | 3.85% |
| Revenue Per Employee | 1.39M |
| Profits Per Employee | 214,040 |
| Employee Count | 1,240 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, HKG:1061 has paid 93.65 million in taxes.
| Income Tax | 93.65M |
| Effective Tax Rate | 26.08% |
Stock Price Statistics
The stock price has decreased by -60.98% in the last 52 weeks. The beta is 0.02, so HKG:1061's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -60.98% |
| 50-Day Moving Average | 2.56 |
| 200-Day Moving Average | 3.46 |
| Relative Strength Index (RSI) | 32.57 |
| Average Volume (20 Days) | 362,525 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1061 had revenue of HKD 1.72 billion and earned 265.41 million in profits. Earnings per share was 0.47.
| Revenue | 1.72B |
| Gross Profit | 1.50B |
| Operating Income | 343.76M |
| Pretax Income | 359.06M |
| Net Income | 265.41M |
| EBITDA | 397.94M |
| EBIT | 343.76M |
| Earnings Per Share (EPS) | 0.47 |
Balance Sheet
The company has 807.73 million in cash and 348.99 million in debt, with a net cash position of 458.74 million or 0.81 per share.
| Cash & Cash Equivalents | 807.73M |
| Total Debt | 348.99M |
| Net Cash | 458.74M |
| Net Cash Per Share | 0.81 |
| Equity (Book Value) | 2.55B |
| Book Value Per Share | 4.50 |
| Working Capital | 905.20M |
Cash Flow
In the last 12 months, operating cash flow was 282.52 million and capital expenditures -64.22 million, giving a free cash flow of 218.29 million.
| Operating Cash Flow | 282.52M |
| Capital Expenditures | -64.22M |
| Depreciation & Amortization | 54.17M |
| Net Borrowing | 35.51M |
| Free Cash Flow | 218.29M |
| FCF Per Share | 0.39 |
Margins
Gross margin is 86.85%, with operating and profit margins of 19.96% and 15.41%.
| Gross Margin | 86.85% |
| Operating Margin | 19.96% |
| Pretax Margin | 20.85% |
| Profit Margin | 15.41% |
| EBITDA Margin | 23.11% |
| EBIT Margin | 19.96% |
| FCF Margin | 12.68% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 6.02%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 6.02% |
| Dividend Growth (YoY) | -7.69% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 29.91% |
| Buyback Yield | 0.42% |
| Shareholder Yield | 6.44% |
| Earnings Yield | 20.66% |
| FCF Yield | 16.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1061 has an Altman Z-Score of 3.4 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.4 |
| Piotroski F-Score | 5 |